Shanghai HepaBiotech
Shanghai HepaBiotech is dedicated to the development and application of advanced 3D microtissue platforms, delivering robust safety, efficacy, and metabolic evaluations to support preclinical drug development. Our founding team originates from the Karolinska Institute, home to the Nobel Assembly for the Nobel Prize in Physiology or Medicine. We have partnered with more than sixty leading pharmaceutical companies worldwide, providing industry-trusted preclinical evaluation solutions that accelerate innovative drug development.
Roper Toxicology Consulting Ltd
I deliver expert support in NAMs specialising in dermal, respiratory, and general in vitro toxicology, MPS, and innovation across industry sectors. Services include existing and new technology evaluation, test method development, regulatory submission support, continuous improvement programs, and authoring scientific papers and expert reports. I also serve as an Expert Witness.
Ncardia
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC).